BIOMARIN PHARMACEUTICAL INC Insider Trading for February 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for February 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28 2018 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Grant | A | 0.00 | 11,523 | 0 | 94,265 | 82.7 K to 94.3 K (+13.93 %) |
| Feb 28 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Grant | A | 0.00 | 20,324 | 0 | 153,885 | 133.6 K to 153.9 K (+15.22 %) |
| Feb 28 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 45,722 | 0 | 272,216 | 226.5 K to 272.2 K (+20.19 %) |
| Feb 28 2018 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 0.00 | 12,529 | 0 | 70,129 | 57.6 K to 70.1 K (+21.75 %) |
| Feb 28 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Grant | A | 0.00 | 12,529 | 0 | 59,918 | 47.4 K to 59.9 K (+26.44 %) |
| Feb 28 2018 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Grant | A | 0.00 | 12,190 | 0 | 81,084 | 68.9 K to 81.1 K (+17.69 %) |
| Feb 20 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 10,000 | 385,900 | 172,500 | |
| Feb 20 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.63 | 10,000 | 846,285 | 226,494 | 236.5 K to 226.5 K (-4.23 %) |
| Feb 20 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 10,000 | 385,900 | 236,494 | 226.5 K to 236.5 K (+4.42 %) |
| Feb 05 2018 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Option Exercise | M | 38.59 | 30,000 | 1,157,700 | 0 | |
| Feb 05 2018 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 90.66 | 30,000 | 2,719,665 | 82,942 | 112.9 K to 82.9 K (-26.56 %) |
| Feb 05 2018 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Buy | M | 38.59 | 30,000 | 1,157,700 | 112,942 | 82.9 K to 112.9 K (+36.17 %) |